Contact Information for Ibrance and Bosutinib With Fulvestrant in Patients With Metastatic HR+ HER2- Breast Cancer Refractory to an Aromatase Inhibitor and a CDK4/6 Inhibitor
Connect
BreastCancerTrials.org
499 Illinois Ave, Suite 200
San Francisco, CA 94158
(888) 282-7099 Help-Desk@bctrials.org
